Can-C the new eye drop developed by IVP and sold by Can-C.biz. Over half a million bottles sold for the reversal of cataracts.
Dr. Mark Babizhayev, the senior research investigator at the prestigious Helmholtz Institute for Ocluar Disease and the founder of Innovative Vision Products (IVP), started his research into aging eye diseases 20 years ago. IVP a US based corporation, have after many years, developed a new form of carnosine known as n-acetylcarnosine or NAC. IVP developed a proprietary method of producing extremely high purity NAC and this NAC is the important ingredient in our eye drops. NAC eye drops present the first major leap forward in the treatment and possible prevention of senile cataract and other aging eye conditions without the need of potentially risky operations or intrusive medical procedures. Early studies had patients instilling 2 drops of NAC eye drops into each eye several times a day, for a period of 6 months. The effective rate was 100% setting an unprecedented benchmark for the treatment and reversal of cataracts and other eye disorders. NAC has a highly statistical and very significant clinical success rate for patients within 6-12 months of treatment. In the last decade, NAC eye drops have generated thousands of reports of safe and effective cataract reversal in both humans and in animals and have sold over 1 million bottles worldwide. NAC eye-drops provide treatment without surgery, and allow the patient to keep their natural lens rather than cope with an artificial one.
Let us bring you immediate traffic to you.
Become part of the Adman Network:
Adman Cool Links